Market Research Industry Reports

Breast Cancer [2017]: Bulletin #1

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS



Gain new KOL insights on the latest events that have the potential to impact the treatment landscape of breast cancer (BC). Topics covered include expert opinions on: Roche announcing results from the Phase III APHINITY study of Perjeta (pertuzumab) as an adjuvant therapy for BC; Merck & Co. announcing data from the Keytruda (pembrolizumab) I-SPY 2 study; as well as the US approval and launch of Nerlynx (neratinib; Puma Biotechnology).



Business Questions:

How do KOLs regard Perjetas magnitude of benefit in the APHINITY trial?
According to KOLs, in which patients will Perjeta be prescribed?
What are KOLs views on Keytruda as a neoadjuvant therapy in triple-negative BC?
How do KOLs view checkpoint inhibitors in general as potential therapies for BC?
How do experts foresee Nerlynx being prescribed in the treatment of BC?
What factors, if any, are likely to impact Nerlynxs uptake?

Breast Pump Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

Breast pump refers to a medical device which is used for extracting breast milk from lactating women. This not only prevents discomfort but also helps to keep infection at bay

USD 1499View Report

Asia-Pacific Breast Prosthesis Market Report 2018

In this report, the Asia-Pacific Breast Prosthesis market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing

USD 4000View Report

Global Breast Cancer Predictive Genetic Testing Market Professional Survey Report 2018

This report studies Breast Cancer Predictive Genetic Testing in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in

USD 3500View Report

United States Breast Cancer Screening Market Report 2018

In this report, the United States Breast Cancer Screening market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of

USD 3800View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 1045
  • Enterprise Wide Licence    USD 2575
$ 1045

Reports Details

Published Date : Aug 2017
Country :Global
Category :Healthcare
Publisher :FirstWord Dossier
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube